NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has exclusively licensed rights to Proteome Sciences’ TMT isobaric mass tag technology, the Cobham, UK-based firm announced yesterday.
 
Proteome Sciences will manufacture the TMT reagents and Thermo Fisher will market and sell them through its Pierce product line. The TMT patents expire in 2021, and Thermo Fisher has the right to provide third-party commercial licenses for use of any type of isobaric tandem mass tags.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.